---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-249298"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:10:13.596488+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics adopts executive severance plan with enhanced change-in-control benefits

## Summary
- Plan covers employees in grades M through P (excluding CEO Blum); severance based on years of service.
- Non-CIC termination: cash lump sum = pro-rated base salary (6–12 months), earned & pro-rated bonus, COBRA.
- CIC termination (within 18 months): severance period 12–18 months, 100% target bonus plus pro-rated bonus.
- Equity awards fully accelerate for CIC terminations, with performance vesting at higher of target or actual.
- Benefits subject to release of claims and compliance with confidentiality and restrictive covenants.

## SEC filing metadata
- accession: 0001193125-23-249298
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000119312523249298/0001193125-23-249298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000119312523249298/d561384d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-249298
- JSON: https://secwatch.observer/filing/0001193125-23-249298.json
- Plain text: https://secwatch.observer/filing/0001193125-23-249298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.